RITSUKO KOMAKI to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Receptors, Vascular Endothelial Growth Factor.
Connection Strength
0.037
-
Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin Cancer Res. 2012 Mar 15; 18(6):1641-54.
Score: 0.021
-
Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1534-43.
Score: 0.016